(Q77372860)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9761417%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

title

Enhancement of immobility in mouse forced swimming test by treatment with human interferon (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9761417%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

author name string

Makino M

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9761417%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

Kitano Y

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9761417%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

Hirohashi M

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9761417%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

Takasuna K

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9761417%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

publication date

1 August 1998

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9761417%20AND%20SRC:MED&resulttype=core&format=json

European Journal of Pharmacology

5 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9761417%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

volume

356

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9761417%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

page(s)

1-7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9761417%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9761417%20AND%20SRC:MED&resulttype=core&format=json

Interferon-induced organic mental disorders associated with unsuspected pre-existing neurologic abnormalities.

5 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900474-9

Alpha-interferon modifies cortical EEG activity: dose-dependence and antagonism by naloxone

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900474-9

Human leukocyte interferon: structural and biological relatedness to adrenocorticotropic hormone and endorphins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900474-9

Common pathways of interferon and hormonal action

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900474-9

Human leukocyte interferon (HuIFN-alpha): potent endorphin-like opioid activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900474-9

Pharmacology and side-effects of interferons.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900474-9

Is the forced swimming test a suitable model for revealing antidepressant activity?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900474-9

Immune response products alter CNS activity: interferon modulates central opioid functions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900474-9

Repeated injections of interferon-alpha A/D in Balb/c mice: behavioral effects.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900474-9

Interferon-alpha stimulates the hypothalamic-pituitary-adrenal axis in vivo and in vitro.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900474-9

Treatment of chronic non-A,non-B hepatitis with recombinant human alpha interferon. A preliminary report

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900474-9

Interferon alpha-2 enhances slow-wave sleep in rabbits.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900474-9

7 January 2021

Interferon receptors.

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900474-9

Human recombinant interferon alpha inhibits naloxone binding to rat brain membranes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900474-9

Persistent neurotoxicity of systemically administered interferon-alpha.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900474-9

Effects of cytokines on the pituitary-adrenal axis in cancer patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900474-9

Depression: a new animal model sensitive to antidepressant treatments

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900474-9

Behavioural despair in rats: A new model sensitive to antidepressant treatments

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900474-9

Clinical toxicity of interferons in cancer patients: a review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900474-9

Central nervous system toxicity of interferon

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900474-9

A new forced swimming test for the evaluation of antidepressants in rats by recording vibration of a water tank

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900474-9

Neurological effects of recombinant human interferon

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900474-9

Clinical toxicity of the interferons.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900474-9

The validity of animal models of depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900474-9

Memory and psychomotor impairment following high-dose interferon treatment in amyotrophic lateral sclerosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900474-9

inferred from DOI database lookup

7 January 2021

based on heuristic

Electroencephalographic abnormalities in interferon encephalopathy: a preliminary report.

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900474-9

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0014-2999(98)00474-9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9761417%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

1 reference